<DOC>
	<DOCNO>NCT01787318</DOCNO>
	<brief_summary>This research study design look well adolescent ' young adult ' blood sugar control `` close loop artificial pancreas '' use continuous glucose sensor , insulin pump , computer program automatically determine much insulin give base glucose level . The investigator also study effect wear small heating patch , InsuPatch , site insulin infusion , ability close loop system control blood sugar level reduce rise glucose level meal .</brief_summary>
	<brief_title>Effect InsuPatch Automated Closed-loop Glucose Control Type 1 Diabetes</brief_title>
	<detailed_description>This open-label , single-center , randomize crossover study evaluate performance closed-loop ( CL ) insulin delivery system use subcutaneous glucose sensor external insulin pump compare peak post-prandial glucose level post-prandial glucose AUC either CL control alone CL control InsuPatch inpatient hospital research unit ( HRU ) setting . The closed loop visit consist approximately 67 hour 4 day 3 night .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1. age 1240 year 2. clinical diagnosis type 1 diabetes 3. duration type 1 diabetes ≥ 1 year 4 . HbA1c ≤ 9 % 5 . Treated pump therapy least 3 month 6 . Body weight &gt; 40 kg 1 . Insulin resistant ( define require &gt; 1.5 units/kg/day time study enrollment 2 . Presence medical psychiatric disorder may interfere subject safety study conduct 3 . Use medication ( besides insulin ) know blood glucose level , include oral systemic glucocorticoid therapy . Inhaled , intranasal , rectal corticosteroid use allow along give within 4 week admission . Use topical glucocorticoid allowable long affected skin area overlap study device site . Subjects use herbal supplement exclude , due unknown effect supplement glucose control 4 . History poor wound healing , heat sensitivity , diminish skin integrity . 5 . History hypoglycemic seizure within last 3 month 6 . Anemic ( low hematocrit ) , evidence renal insufficiency ( elevate serum creatinine ) 7 . Female subject pregnant , lactating , unwilling test pregnancy 8 . Subjects unable give consent / permission / assent</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>